Matthieu Koszutski

Matthieu Koszutski

Auto-generated profile, based on publicly available information

Matthieu Koszutski

CHRU de Nancy, Médecine Intensive et Réanimation Brabois, Université de Lorraine, Nancy, France

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2020 in Clinical Kidney Journal
Verified
Journal Article
Open access
RKRaphaël Kormann
Raphaël Kormann
AJAudrey Jacquot
Audrey Jacquot
AAAsma Alla
Asma Alla
ACAlice CORBEL
Alice CORBEL
MKMatthieu Koszutski
Matthieu Koszutski
AOAbderrahim Oussalah
Abderrahim Oussalah
Background: Recent data have shown that severe acute respiratory syndrome coronavirus 2 can infect renal proximal tubular cells via Angiotensin Converting Enzyme 2 (ACE2) . Our objective was to determine whether Fanconi syndrome is a frequent clinical feature in coronavirus disease 2019 (COVID-19) patients. Methods: A retrospective cohort of 42 laboratory-confirmed COVID-19 patients without history of kidney disease hospitalized in University Hospital of Nancy was investigated. Patients were admitted to the intensive care unit (ICU) (n = 28) or the Medical department (n = 14) and were screened at least once for four markers of proximal tubulopathy. Results: The mean (standard deviation) follow-up was 19.7 (±12.2) days. Of the patients, 75% (30/40) showed at least two proximal tubule abnormalities (incomplete Fanconi syndrome). The main disorders were proteinuria (88%, n = 35), renal phosphate leak defined by renal phosphate threshold/glomerular filtration rate (TmPi/GFR) <0.77 (55%, n = 22), hyperuricosuria (43%, n = 17) and normoglycaemic glycosuria (30%, n = 12). At the time of the first renal evaluation, ICU patients presented more frequent (96 versus 62%, P = 0.0095) and more severe (844 ± 343 versus 350 ± 221 mg/g, P = 0.0001) proteinuria, and a trend for an increased number of proximal tubule abnormalities (P = 0.038). During follow-up, they presented a lower nadir of serum phosphate [median (interquartile range) 0.68 (0.43–0.76) versus 0.77 (0.66–1.07) mmol/L, P = 0.044] and Acute kidney Injury (AKI) during the hospitalization (P = 0.045). Fanconi syndrome preceded severe AKI KDIGO Stages 2 and 3 in 88% (7/8) of patients. Proximal tubular abnormalities (such as proteinuria, TmPi/GFR and glycosuria in five, two and two patients, respectively) were not detected anymore in recovering patients before hospital discharge. Conclusion: Incomplete Fanconi syndrome is highly frequent in COVID-19 patients and precedes AKI or disappears during the recovery phase.

31 July 2021 in Critical Care
Verified
Journal Article
Open access
PDF file
MKMatthieu Koszutski
Matthieu Koszutski
MMMathieu Mattei
Mathieu Mattei
JMJuan Pablo Maureira
Juan Pablo Maureira
AKAntoine Kimmoun
Antoine Kimmoun
Bruno LévyBruno Lévy
Bruno Lévy
Trial registration: ClinicalTrials.gov Identifier: NCT03910062.

28 March 2018 in Revue des Maladies Respiratoires
Verified
Journal Article
Closed access
MKM. Koszutski
M. Koszutski
MFM. Faure
M. Faure
AGA. Guillaumot
A. Guillaumot
EGE. Gomez
E. Gomez
MMM. Mercy
M. Mercy
ACA. Chaouat
A. Chaouat

17 December 2020 in Research Square
Verified
Preprint
Open access
PDF file
MKMatthieu Koszutski
Matthieu Koszutski
BPBenjamin Pequignot
Benjamin Pequignot
AKAntoine Kimmoun
Antoine Kimmoun
TRThomas Remen
Thomas Remen
PGPhilippe Guerci
Philippe Guerci
BLBruno Levy
Bruno Levy
Background:To evaluate the switching of patients mechanically ventilated on Pressure Support or Volume Control to inverse-ratio Airway Pressure Release Ventilation (APRV) during the COVID-19 pandemic.Methods:We performed a single-center retrospective observational analysis in two ICUs in a tertiary referral university teaching hospital in France. Were included patients with Covid-19 pneumonia requiring invasive ventilation with a PaO2:FiO2 ratio lower than 200 mmHg who performed a 6-hour trial of inverse-ratio APRV.Results:Seventeen consecutive patients who completed a 6-hour APRV trial in April 2020 were included. Three patients who were unable to be maintained on APRV due to an immediate fall in SpO2 were not included. In 12/17 patients (71%), the increase in PaO2:FiO2 ratio was greater than 20%. Mean (± standard deviation) PaO2:FiO2 ratio increased from 126 (± 28) mmHg to 178 (± 53) mmHg after 6 hours of APRV (p<0.001). Two patients presented a decrease in PaO2:FiO2 ratio after 6 hours of APRV. There was no appearance of significant hemodynamic impairment during APRV and an eventual increase in PaCO2 during the first hour of APRV was managed by increasing the respiratory rate (i.e. shortening T-high) and/or increasing tidal volume (i.e. increasing T-low).Conclusions:Switching from Conventional Ventilation (Pressure Support or Volume Assist Control) to inverse-ratio APRV for a 6-hour period in two ICUs that were not previously familiar with this ventilation technique was well tolerated, and associated with a marked improvement in oxygenation. Further studies evaluating inverse-ratio APRV in acute respiratory failure are warranted.Trial registration:NCT04386369

1 June 2018 in Journal Européen des Urgences et de Réanimation
Verified
Journal Article
Closed access
ACA. Clémençot
A. Clémençot
MJM. Jnan
M. Jnan
MKM. Koszutski
M. Koszutski

18 February 2019 in Journal of Investigational Allergology and Clinical Immunology
Verified
Journal Article
Closed access
SVS Valentin
S Valentin
BBB Ribeiro Baptista
B Ribeiro Baptista
LPL Peretti
L Peretti
MKM Koszutski
M Koszutski